A first ray of hope for Ebola patients in the Democratic Republic of the Congo as the trial of two potential treatments for the virus gets underway.

The Bundibugyo strain has no approved vaccine or targeted treatment, leaving supportive care as the primary option.

More than 1,400 people have been diagnosed and 438 have died